| RESEARCH SITES |
|
| Year : 2010 | Volume
: 1
| Issue : 3 | Page : 106-109 |
|
|
Conducting feasibilities in clinical trials: An investment to ensure a good study
Viraj Rajadhyaksha
Senior Manager, Operations, Planning and Management, Clinical Research, Pfizer Ltd, Mumbai, India
Correspondence Address:
Viraj Rajadhyaksha
Senior Manager, Operations, Planning and Management, Clinical Research, Pfizer Ltd, Mumbai
India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21814631 
|
|
|
Conducting clinical trial feasibility is one of the first steps in clinical trial conduct. This process includes assessing internal and environmental capacity, alignment of the clinical trial in terms of study design, dose of investigational product, comparator, patient type, with the local environment and assessing potential of conducting clinical trial in a specific country. A robust feasibility also ensures a realistic assessment and capability to conduct the clinical trial. For local affiliates of pharmaceutical organizations, and contract research organizations, this is a precursor to study placement and influences the decision of study placement. This article provides details on different types of feasibilities, information which is to be included and relevance of each. The article also aims to provide practical hands-on suggestions to make feasibilities more realistic and informative. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
